N. Marks

发表

R. Rodnight, Neville Marks, Richard Rodnight, 2013, Springer US.

BACE and γ-Secretase Characterization and Their Sorting as Therapeutic Targets to Reduce Amyloidogenesis

Neville Marks, Martin J. Berg, N. Marks, 2010, Neurochemical Research.

Identification of membrane‐bound carbonic anhydrase in white matter coated vesicles: The fate of carbonic anhydrase and other white matter coated vesicle proteins in triethyl tin‐induced leukoencephalopathy

V. Sapirstein, N. Marks, R. Durrie, 1993, Journal of neuroscience research.

Brain cathepsin B but not metalloendopeptidases degrade rAPP751 with production of amyloidogenic fragments. Comparison with synthetic peptides emulating beta- and gamma-secretase sites.

W. Danho, V. Sapirstein, J. Swistok, 2009, International journal of peptide and protein research.

SUBCELLULAR LOCALIZATION AND PARTIAL PURIFICATION OF A CHLORIDE DEPENDENT ANGIOTENSIN‐I CONVERTING ENZYME FROM RAT BRAIN

M. Benuck, N. Marks, 1978, Journal of neurochemistry.

Protracted form of Canavan's disease: Case history and protein kinase activity of membrane fractions

N. Marks, D. Boehme, 2004, Acta Neuropathologica.

Activation of caspase‐3 and apoptosis in cerebellar granule cells

A. Guidotti, M. Saito, N. Marks, 1998, Journal of neuroscience research.

Inactivation of somatostatin (GH‐RIH) and its analogs by crude and partially purified rat brain extracts

N. Marks, F. Stern, 1975, FEBS letters.

Preferential action of rat brain cathepsin B as a peptidyl dipeptidase converting pro-opioid oligopeptides.

M. Benuck, N. Marks, M. Berg, 1986, Archives of biochemistry and biophysics.

Regulatory mechanisms in focal ischemic stroke

Z. Nagy, N. Marks, M. Berg, 2002 .

Neurosecretases provide strategies to treat sporadic and familial Alzheimer disorders

N. Marks, M. Berg, 2008, Neurochemistry International.

APP Processing Enzymes (Secretases) as Therapeutic Targets: Insights from the Use of Transgenics (Tgs) and Transfected Cells

N. Marks, M. Berg, 2003, Neurochemical Research.

Conversion of met-enkephalin-Arg6-Phe7 by a purified brain carboxypeptidase (cathepsin A)

L. Sachs, N. Marks, F. Stern, 1981, Peptides.

Differential expression of carnosine, homocarnosine and N-acetyl-L-histidine hydrolytic activities in cultured rat macroglial cells

R. Suckow, K. Bhakoo, M. Baslow, 2001, Journal of Molecular Neuroscience.

Hydrolysis of amyloid precursor protein-derived peptides by cysteine proteinases and extracts of rat brain clathrin-coated vesicles

L. Chi, W. Danho, V. Sapirstein, 1994, Peptides.

Correlation between biological potency and biodegradation of a somatostatin analogue

M. Benuck, N. Marks, F. Stern, 1976, Nature.

ON THE METABOLISM OF OPIATE PEPTIDES BY BRAIN PROTEOLYTIC ENZYMES

M. Benuck, V. Turk, N. Marks, 1981 .

Protein and Polypeptide Breakdown

A. Lajtha, N. Marks, 1971 .

On the degradation of enkephalins and endorphins by rat and mouse brain extracts.

A. Neidle, N. Marks, A. Grynabaum, 1977, Biochemical and biophysical research communications.

Differences in the degradation of hypothalamic releasing factors by rat and human serum.

M. Benuck, N. Marks, 1976, Life sciences.

Proteolytic enzymes in ordinary, hyperacute, monocytic and passive transfer forms of experimental allergic encephalomyelitis

S. Levine, A. Grynbaum, N. Marks, 1977, Brain Research.

Rat brain and kidney metalloendopeptidase: enkephalin heptapeptide conversion to form a cardioactive neuropeptide, Phe-Met-Arg-Phe-amide.

M. Benuck, N. Marks, M. Berg, 1982, Biochemical and biophysical research communications.

A distinct peptidyl dipeptidase that degrades enkephalin: exceptionally high activity in rabbit kidney.

M. Benuck, N. Marks, M. Berg, 1981, Life sciences.

Lead (Pb+2) promotes apoptosis in newborn rat cerebellar neurons: pathological implications.

A. Guidotti, N. Marks, H. L. Evans, 1996, The Journal of pharmacology and experimental therapeutics.

Neuronal endosomal/lysosomal membrane destabilization activates caspases and induces abnormal accumulation of the lipid secondary messenger ceramide

Stefani N. Thomas, A. Yang, M. Saito, 2003, Brain Research Bulletin.

Specificity of Breakdown Based on the Inactivation of Active Proteins and Peptides by Brain Proteolytic Enzymes

N. Marks, 1977 .

Changes in proteolytic enzymes and proteins during maturation of the brain

A. Lajtha, N. Marks, F. Stern, 1975, Brain Research.

Enzymatic mechanisms for the inactivation of luteinizing hormone-releasing hormone (LH-RH).

N. Marks, F. Stern, 1974, Biochemical and biophysical research communications.

PROTEIN AND PEPTIDE HYDROLASES OF THE RAT HYPOTHALAMUS AND PITUITARY

A. Lajtha, A. Galoyan, A. Grynbaum, 1974, Journal of neurochemistry.

Breakdown of bradykinin and its analogs by rat brain neutral proteinase.

N. Marks, M. Pirotta, 1971, Brain research.

Opposite Effects of Lithium on Proximal and Distal Caspases of Immature and Mature Primary Neurons Correlate with Earlier Paradoxical Actions on Viability

A. Yang, M. Saito, Maurice Green, 2001, Neurochemical Research.

Observations on Nα‐Deacetylation of Model Amino Acids and Peptides: Distribution and Purification of a Specific N‐Acyl Amino Acid Releasing Enzyme in Rat Brain

W. Danho, N. Marks, F. Stern, 1983, Journal of neurochemistry.

Purification and properties of brain cathepsin B. Evidence for cleavage of pituitary lipotropins.

N. Marks, A. Suhar, 1979, European journal of biochemistry.

Lipoperoxidation in human and rat brain tissue: Developmental and regional studies

N. Marks, D. Boehme, F. Stern, 1977, Brain Research.

Preparation of Brain Mitochondrial Membranes

N. Marks, 1974 .

Co-identity of brain angiotensin converting enzyme with a membrane bound dipeptidyl carboxypeptidase inactivating Met - enkephalin.

M. Benuck, N. Marks, 1979, Biochemical and biophysical research communications.

Degradation of encephalitogen by purified brain acid proteinase

N. Marks, E. Einstein, J. Csejtey, 1968, FEBS letters.

Biodegradation of α-MSH and derived peptides by rat brain extracts, and by rat and human serum

A. Kastin, N. Marks, F. Stern, 1976, Brain Research Bulletin.

Enzymatic inactivation of substance P by a partially purified enzyme from rat brain.

M. Benuck, N. Marks, 1975, Biochemical and biophysical research communications.

Breakdown of somatostatin and substance P by cathepsin D purified from calf brain by affinity chromotography

M. Benuck, A. Grynbaum, N. Marks, 1978, Brain Research.

Metabolic instability of myelin proteins. Breakdown of basic protein induced by brain cathepsin D.

M. Benuck, G. Hashim, N. Marks, 1975, European journal of biochemistry.

Hydrolysis of myelin basic protein with brain acid proteinase.

M. Benuck, G. Hashim, N. Marks, 1974, Biochemical and biophysical research communications.

Treatment of experimental allergic encephalomyelitis with an inhibitor of cathepsin D (pepstatin)

G. Hashim, H. Umezawa, N. Marks, 1978, Neurochemical Research.

Diversity of rat brain cysteine proteinase inhibitors: isolation of low-molecular-weight cystatins and a higher-molecular weight T-kininogen-like glycoprotein.

L. Chi, N. Marks, M. Berg, 1988, Archives of biochemistry and biophysics.

Cerebrocystatin suppresses degradation of myelin basic protein by purified brain cysteine proteinase.

N. Marks, F. Stern, M. Kopitar, 1983, Biochemical and biophysical research communications.

Specificity of brain cathepsin D: Cleavage of model peptides containing the susceptible phe‐phe regions of myelin basic protein

M. Benuck, G. Hashim, N. Marks, 1980, Journal of neuroscience research.

Mitigation of experimental allergic encephalomyelitis by cathepsin D inhibition.

N. Marks, D. Boehme, 1979, Advances in experimental medicine and biology.

ON THE SEQUENTIAL CLEAVAGE OF MYELIN BASIC PROTEIN BY CATHEPSINS A AND D

M. Benuck, A. Grynbaum, N. Marks, 1976, Journal of neurochemistry.

CHARACTERIZATION OF A RAT BRAIN CATHEPTIC CARBOXYPEPTIDASE (CATHEPSIN A) INACTIVATING ANGIOTENSIN‐II

A. Grynbaum, N. Marks, 1976, Journal of neurochemistry.

Proteolytic activity in brain and spinal cord in sensitive and resistant strains of rat and mouse subjected to experimental allergic encephalomyelitis.

N. Marks, D. Boehme, M. W. Fordice, 1974, Brain research.

Peptide hydrolases in spinal cord and brain of the rabbit.

A. Lajtha, A. Grynbaum, N. Marks, 1972, Brain research.

Separate metabolic pathways for Leu-enkephalin and Met-enkephalin-Arg6-Phe7 degradation by rat striatal synaptosomal membranes

M. Benuck, N. Marks, M. Berg, 1982, Neurochemistry International.

METABOLISM OF ENKEPHALIN ANALOGUES AND SURROGATES HAVING ENHANCED PHARMACOLOGIC ACTIVITIES *

M. Benuck, L. Sachs, N. Marks, 1982, Annals of the New York Academy of Sciences.

Metabolism of a heptapeptide opioid by rat brain and cardiac tissue.

M. Benuck, N. Marks, M. Berg, 1982, Life sciences.

Met-enkephalin-Arg6-Phe7 metabolism: conversion to Met-enkephalin by brain and kidney dipeptidyl carboxypeptidases.

M. Benuck, N. Marks, M. Berg, 1981, Biochemical and biophysical research communications.

Metabolic regulation of β-endorphin levels in perspective

A. Lajtha, N. Marks, 1979 .

Conversion of lipotropic peptides by purified cathepsin D of human pituitary: Release of γ-endorphin by cleavage of the Leu77-PHE78 bond

T. Cooper, M. Benuck, A. Grynbaum, 1978, Neuroscience Letters.

In Vivo Perturbation of Lysosomal Function Promotes Neurodegeneration in the PS1M146V/APPK670N,M671L Mouse Model of Alzheimer's Disease Pathology

H. Sershen, S. Schmidt, P. Mathews, 2002 .

Characterization of a distinct membrane bound dipeptidyl carboxypeptidase inactivating enkephalin in brain.

M. Benuck, N. Marks, 1980, Biochemical and biophysical research communications.

The C-fragment of beta-lipotropin: an endogenous neuroleptic or antipsychotogen?

N. Marks, Y. Jacquet, 1976, Science.

Synthesis and biological evaluation of phosphonamidate peptide inhibitors of enkephalinase and angiotensin-converting enzyme.

P. Portoghese, N. Marks, M. Berg, 1985, Journal of medicinal chemistry.

Protein metabolism in cerebral mitochondria. I. Hydrolytic enzymes and amino acid incorporation into mitochondrial membranes.

A. Lajtha, C. Bellman, N. Marks, 1970, Brain research.

Protein Turnover in Membranous Fractions

A. Lajtha, N. Marks, R. K. Datta, 1970 .

Metabolic Turnover in the Nervous System

R. L. Herrmann, A. Lajtha, L. Sokoloff, 1971, Springer US.

Pentapeptide (Pepstatin) Inhibition of Brain Acid Proteinase

A. Lajtha, A. Grynbaum, N. Marks, 1973, Science.

Metabolic Turnover in the Nervous System

P. Greengard, A. Lajtha, J. M. Ritchie, 1971, Springer US.

Developmental Changes in Peptide-Bond Hydrolases

A. Lajtha, N. Marks, 1970 .

DISTRIBUTION OF AMINO ACIDS AND OF EXO‐ AND ENDOPEPTIDASES ALONG VERTEBRATE AND INVERTEBRATE NERVES

A. Lajtha, N. Marks, R. K. Datta, 1970, Journal of neurochemistry.

Protein phosphorylation in human synaptosomal membranes: Evidence for the presence of substrates for cyclic nucleotide guanosine 3′–5′-monophosphate dependent protein kinases

N. Marks, D. Boehme, R. Kosecki, 1978, Brain Research Bulletin.

Exopeptidases of the nervous system.

N. Marks, 1968, International review of neurobiology.

Gangliosides Attenuate Ethanol-Induced Apoptosis in Rat Cerebellar Granule Neurons

A. Guidotti, M. Saito, N. Marks, 1999, Neurochemical Research.

Glucosylceramide synthase decrease in frontal cortex of Alzheimer brain correlates with abnormal increase in endogenous ceramides: Consequences to morphology and viability on enzyme suppression in cultured primary neurons

M. Saito, N. Marks, M. Berg, 2008, Brain Research.

Conversion and Inactivation of Neuropeptides

N. Marks, 1977 .

Evidence for conversion of N-Tyr-MIF-1 into MIF-1 by a specific brain aminopeptidase

A. Kastin, D. Coy, N. Marks, 1984, Neurochemistry International.

Glycine levels in the degenerated human spinal cord

N. Marks, D. Boehme, M. W. Fordice, 1976, Journal of the Neurological Sciences.

Recent advances on neuronal caspases in development and neurodegeneration

N. Marks, M. Berg, 1999, Neurochemistry International.

Amyloid ( Tace, Bace ) and Presenilin Proteases Associated with Alzheimer’s Disease

N. Marks, M. Berg, 2002 .

Secretase Processing of Amyloid Precursor Protein (APP) and Neurodegeneration

N. Marks, M. Berg, 2007 .

Degradation of luteinizing hormone—Releasing hormone (LHRH) by brain prolyl endopeptidase with release of des-glycinamide LHRH and glycinamide

M. Benuck, M. Orłowski, S. Wilk, 1979, Neuroscience Letters.

Metabolic instability of myelin protein and proteolipid fractions.

P Mela, P. Mela, B D'Monte, 1971, European journal of biochemistry.

Separation of acid and neutral proteinases of brain.

A. Lajtha, N. Marks, 1965, The Biochemical journal.

PROTEIN BREAKDOWN IN THE BRAIN. SUBCELLULAR DISTRIBUTION AND PROPERTIES OF NEUTRAL AND ACID PROTEINASES.

A. Lajtha, N. Marks, 1963, The Biochemical journal.

Intracellular Protein Catabolism II

A. Barrett, J. Woessner, V. Turk, 1977, Springer US.

Partial resolution of brain arylamidases and aminopeptidases.

A. Lajtha, N. Marks, R. K. Datta, 1968, The Journal of biological chemistry.

Transduction of E13 murine neural precursor cells by non-immunogenic recombinant adeno-associated viruses induces major changes in neuronal phenotype

N. Marks, M. Berg, K. Nash, 2012, Neuroscience.

Brain damage results in down-regulation of N-acetylaspartate as a neuronal osmolyte

R. Suckow, Y. Matsuoka, Kate Gaynor, 2007, NeuroMolecular Medicine.

Amyloid precursor protein is enriched in axolemma and periaxolemmal‐myelin and associated clathrin‐coated vesicles

V. Sapirstein, N. Marks, M. Berg, 1994, Journal of neuroscience research.

Distribution of glycine in human spinal cord and selected regions of brain.

W. Vogel, N. Marks, D. Boehme, 1973, Brain research.

Rat brain cathepsin L: characterization and differentiation from cathepsin B utilizing opioid peptides.

N. Marks, M. Berg, 1987, Archives of Biochemistry and Biophysics.

Brain cysteine proteinase inhibitors II: Evidence that a 21‐kDa papain‐binding component resembles ras p21

N. Marks, M. Berg, 1991, Journal of neuroscience research.

Synthetic domains of cystatins linked to enkephalins are novel inhibitors of brain cathepsins L/B

W. Danho, N. Marks, R. Makofske, 1990, Peptides.

Enkephalin analogs as substrates for the assay of brain cysteine proteinase (Cathepsin L) and its endogenous inhibitors

W. Danho, N. Marks, M. Berg, 1989, Peptides.

Formation of desTyr dynorphins 5–17 by a purified cytosolic aminopeptidase of rat brain

N. Marks, M. Berg, 1984, Journal of neuroscience research.

Dynamics of Protein Metabolism in the Nervous System

A. Lajtha, N. Marks, 1969 .

Composition of white matter bovine brain coated vesicles: evidence that several components influence β-amyloid peptide to form oligomers and aggregates in vitro

V. Sapirstein, N. Marks, M. Berg, 1997, Brain Research.

Inhibition of brain angiotensin‐1 converting enzyme by Bothrops jararaca nonapeptide (SQ 20881) and a prolyl analog (SQ 14225)

M. Benuck, N. Marks, 1978, Journal of neurochemistry.

Enzymatic degradation of the encephalitogenic protein.

A. Lajtha, N. Marks, E. Einstein, 1969, International archives of allergy and applied immunology.

The Semisynthetic Glycosphingolipid LIGA20 Potently Protects Neurons Against Apoptosis

N. Marks, M. Berg, Mariko Saito, 1998, Annals of the New York Academy of Sciences.

The breakdown of myelin-bound proteins by intra- and extracellular proteases

A. Lajtha, A. Grynbaum, N. Marks, 1976, Neurochemical Research.

Prodynorphin processing by rat CNS fractions and purified enzymes: Formation of Dynorphin A 1–8 by sulfhydryl-activated carboxypeptidase and peptidyl dipeptidase

M. Benuck, C. Seyfried, N. Marks, 1987, Neurochemistry International.

Breakdown of enkephalin and endorphin analogs by brain extracts

A. Kastin, D. Coy, A. Grynbaum, 1977, Brain Research Bulletin.

Metabolism of potent enkephalin analogs (FK 33–824, D-Ala2, pentafluorophenylalanine-4-enkephalinamide and a dimer of D-Ala2-enkephalin) and D-amino acid substituted derivatives of human β-endorphin

A. Kastin, D. Coy, N. Marks, 1978, Brain Research Bulletin.

Degradation of delta sleep inducing peptide (DSIP) and its analogs by brain extracts

A. Kastin, D. Coy, N. Marks, 1977, Brain Research Bulletin.

A highly specific aminotripeptidase of rat brain cytosol. Substrate specificity and effects of inhibitors.

L. Sachs, N. Marks, 1982, Biochimica et biophysica acta.

Myelin enzymes and protein metabolism.

N. Marks, 1972, Advances in Experimental Medicine and Biology.